KAIROS THERAPEUTICS
Kairos Therapeutics is a biopharmaceutical company with a proprietary next-generation antibody-drug conjugate platform.
KAIROS THERAPEUTICS
Industry:
Biotechnology Life Science Medical
Founded:
2013-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.kairostherapeutics.com
Total Employee:
51+
Status:
Closed
Contact:
(206) 237-1030
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Amazon Microsoft Azure DNS DNS Made Easy DNS
Investors List
Accel-Rx Health Sciences Accelerator
Accel-Rx Health Sciences Accelerator investment in Pre Seed Round - Kairos Therapeutics
Official Site Inspections
http://www.kairostherapeutics.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Kairos Therapeutics"
Kairos Therapeutics - Crunchbase Company Profile & Funding
Kairos Therapeutics is located in Vancouver, British Columbia, Canada. Who invested in Kairos Therapeutics? Kairos Therapeutics is funded by Accel-Rx Health Sciences Accelerator. When …See details»
Cutting-edge therapeutics for cancer patients | Kairos …
Kairos Pharma is a clinical-stage biopharmaceutical company that has developed novel therapies to overcome resistance to cancer drugs and reverse cancer-induced immune suppression.. The word “Kairos” means “the opportune …See details»
Kairos Therapeutics Company Profile 2024: Valuation, Investors ...
Kairos Therapeutics General Information Description. Developer of antibody-drug conjugate therapeutics for cancer. The company provides an antibody-drug conjugate platform that …See details»
About | Kairos Pharma
About Kairos Pharma Cutting-Edge Cancer Solutions Backed by science and driven by innovation, we are redefining the future of cancer treatment. Learn More A New Era In Cancer Therapy Pioneering Breakthroughs in Cancer Treatment …See details»
Kairos Therapeutics Inc - Company Profile and News
Company profile page for Kairos Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Kairos Pharma, Ltd. - Investor Relations
Feb 11, 2025 Company Overview. Kairos Pharma is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies designed to overcome drug resistance and …See details»
Kairos Pharma: Creating Therapeutics to Reverse Cancer Drug …
We caught up with Dr. John Yu, CEO & Chairman of Kairos Pharma (NYSE AM: KAPA) to discuss their novel therapies to overcome resistance to cancer drugs. See details»
Kairos Therapeutic Retreat (@kairostherapeutics) - Instagram
Kairostherapeutics. Follow. Message. 32 posts. 122 followers. 134 following. Kairos Therapeutic Retreat. Nonprofit organization. Providing a sanctuary of healing and an ecosystem for …See details»
Kairos Therapeutics - Products, Competitors, Financials, Employees ...
Kairos Therapeutics is a biopharmaceutical company with a proprietary next-generation antibody-drug conjugate platform based on novel toxin, linker, and site-specific conjugation technology. …See details»
Kairos Pharma Ltd. (NYSE: KAPA) | LinkedIn
Kairos Pharma CEO John Yu joined Steve Darling from Proactive to share major updates on the company’s latest cancer research developments. A significant milestone in its academic …See details»
Kairos Therapeutics’s Competitors, Revenue, Number of ... - Owler
Kairos Therapeutics’s Profile, Revenue and Employees. Kairos Therapeutics discovers and develops antibody-drug conjugate therapeutics for the treatment of multiple forms of cancer. …See details»
Pipeline | Kairos Pharma
Pipeline The Kairos Pharma Portfolio of Innovative Therapeutics Our pipeline is focused on addressing critical unmet medical needs in cancer care and beyond. By combining …See details»
Kairos Pharma Ltd. (NYSE American: KAPA)
Investment Considerations Kairos Pharma Ltd. (NYSE American: KAPA) is a clinical-stage biopharmaceutical company focused on advancing innovative oncology therapeutics that …See details»
Kairos Pharma (KAPA) Company Profile & Description - Stock …
Mar 14, 2025 Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company, develops therapeutics for cancer patients. Its therapeutics include antibodies and small molecules for …See details»
Zymeworks and Kairos Therapeutics Enter into Strategic …
Kairos Therapeutics is developing a pipeline of antibody-drug conjugate therapeutics based on a proprietary toxin, linker and site-specific conjugation platform. The platform, which is currently …See details»
Zymeworks and Kairos Therapeutics Enter into Strategic …
About Kairos Therapeutics Inc.: Kairos Therapeutics is a biopharmaceutical company with a proprietary next-generation antibody-drug conjugate platform based on novel toxin, linker, and …See details»
Prevail Partners and Prevail InfoWorks Enter Into Strategic …
Sep 25, 2024 Prevail InfoWorks, a global full-service Clinical Research Organization, has agreed to support Kairos with clinical services and technologies in two upcoming clinical trials: a …See details»
Kairos goes public with $6M IPO to fund trials of cancer drug
Sep 17, 2024 Behind ENV 105 are preclinical candidates like KROS 101, a small molecule agonist for the GITR ligand, which is designed to promote T cell growth and cytotoxic function …See details»
Kairos Pharma Presents Preclinical Data on its Investigational ...
Feb 26, 2025 Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announced that the company presented preclinical data on its inSee details»
Kairos Pharma Doses First Patient in Phase 2 Trial of Lead
LOS ANGELES, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Kairos Pharma, Ltd., a clinical stage biopharmaceutical company developing cancer therapeutics designed to...See details»